The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Numerous longevity genes have been discovered in model organisms and altering their function results in prolonged lifespan. In mammals, some have speculated that any health benefits derived from manipulating these same pathways might be offset by increased cancer risk on account of their propensity to boost cell survival. The Sir2/SIRT1 family of NAD(+)-dependent deacetylases is proposed to underlie the health benefits of calorie restriction (CR), a diet that broadly suppresses cancer in mammals. Here we show that CR induces a two-fold increase SIRT1 expression in the intestine of rodents and that ectopic induction of SIRT1 in a beta-catenin-driven mouse model of colon cancer significantly reduces tumor formation, proliferation, and animal morbidity in the absence of CR. We show that SIRT1 deacetylates beta-catenin and suppresses its ability to activate transcription and drive cell proliferation. Moreover, SIRT1 promotes cytoplasmic localization of the otherwise nuclear-localized oncogenic form of beta-catenin. Consistent with this, a significant inverse correlation was found between the presence of nuclear SIRT1 and the oncogenic form of beta-catenin in 81 human colon tumor specimens analyzed. Taken together, these observations show that SIRT1 suppresses intestinal tumor formation in vivo and raise the prospect that therapies targeting SIRT1 may be of clinical use in beta-catenin-driven malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“We and other researchers have gathered compelling evidence, from yeast to mammals, supporting the idea that a loss of epigenetic information, resulting in changes in gene expression, leads to the loss of cellular identity [3–7].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · cited 1×
“b-catenin is the central effector in the canonical Wnt signaling pathway that controls stem cell maintenance, development and carcinogenesis [20].”
BackgroundActivation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905 · cited 1×
“. Constitutive activation of the β-catenin pathway has been found in 90% of colorectal cancers”
BackgroundModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“On the other hand, SIRT1 can be proapoptotic [12] and anti-proliferative [13,14], and consequently has been proposed to behave as a tumor suppressor in vivo.”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationIncreased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564 · cited 2×
“Interestingly, two recent studies have shown that increased Wnt signaling is associated with accelerated aging, suggesting that an attenuation of Wnt signaling might underlie CR and be beneficial not only for treating cancer but for more broadly attenuating diseases of aging [23,24].”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Self-citationAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“of the second allele leads to constitutive nuclear localization of bcatenin and adenoma formation [18,19].”
BackgroundSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Cited by
Items 201–300 of 603
Powell, M. J., Casimiro, M. C., Cordon‐Cardo, C., He, X., Yeow, W.-S., Wang, C., McCue, P. A., McBurney, M. W., & Pestell, R. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3172 · Cited by 76
“Additional studies from Sirt1 and transgenic mice are consistent with a role for Sirt1 in tumor suppression as Sirt1 was shown to suppress intestinal tumorigenesis and colon cancer (9).”
BackgroundThe emergence of melatonin in oncology: Focus on colorectal cancer
Gil‐Martín, E., Egea, J., Reiter, R. J., & Romero, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21582 · Cited by 71
“Conversely, other findings support SIRT1 as a CRC suppressor which stabilizes cytosolic β‐catenin and survivin by deacetylation.(306) Despite these seeming contradictions and the differences to be taken into account regarding the origin of the tested biological material and/or the experimental settings among studies,(…”
ResultStoyas, C. A., Bushart, D. D., Switonski, P. M., Ward, J. M., Alaghatta, A., Tang, M., Niu, C., Wadhwa, M., Huang, H., Savchenko, A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.019 · Cited by 74
“To achieve Sirt1 over-expression, we obtained a Sirt1 targeted transgenic model, where the Sirt1 cDNA is regulated by a strong ubiquitous promoter-enhancer with a floxed STOP cassette, at the Collagen A1 locus (Firestein et al., 2008); we crossed these mice with CMV-Cre driver mice to derive mice that ubiquitously ove…”
MethodJung-Hynes, B., & Ahmad, N. (2009) · The FASEB Journal · doi:10.1096/fj.09-129148 · Cited by 67
Wauters, E., Lobo, V. J. S.-A., Pinho, A. V., Mawson, A., Herranz, D., Wu, J., Cowley, M. J., Colvin, E. K., Njicop, E. N., Sutherland, R. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3359 · Cited by 74
“We hypothesized that b-catenin could be a target for deacetylation by Sirt1 in ADM as in colon cancer (26).”
BackgroundSIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress
McBurney, M. W., Clark-Knowles, K. V., Caron, A. Z., & Gray, D. A. (2013) · Genes & Cancer · doi:10.1177/1947601912474893 · Cited by 72
“On the one hand, transgenic mice that moderately overexpress SIRT1 were reported to develop slightly fewer spontaneous carcinomas and sarcomas,(143) and mice that overexpress SIRT1 in intestinal epithelium developed fewer polyps in the APC mouse model of colon cancer.(144) However, Sirt1 mice are not tumor prone, and…”
BackgroundNoguchi, A., Kikuchi, K., Zheng, H., Takahashi, H., Miyagi, Y., Aoki, I., & Takano, Y. (2014) · Cancer Medicine · doi:10.1002/cam4.310 · Cited by 68
“In addition, SIRT1 overexpression in Apc mice induces b-catenin deacetylation and reduces colon tumor formation [8].”
BackgroundCellular Compartmentation and the Redox/Nonredox Functions of NAD +
Kulkarni, C. A., & Brookes, P. S. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7722 · Cited by 63
“In cancer, evidence exists for both tumor prevention (44) and promotion by SIRT1 (84).”
BackgroundBao, J., & Sack, M. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0402-y · Cited by 67
“In mice, overexpression of SIRT1 significantly reduces colon cancer formation, proliferation, and animal morbidity by interaction with b-catenin [97].”
Han, Y., Luo, H., Wang, H., Cai, J., & Zhang, Y. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1386-y · Cited by 73
Galangin Induces Autophagy via Deacetylation of LC3 by SIRT1 in HepG2 Cells
Li, X., Wang, Y., Xiong, Y., Wu, J., Ding, H., Chen, X., Lan, L., & Zhang, H. (2016) · Scientific Reports · doi:10.1038/srep30496 · Cited by 71
Nutritional Regulation of Intestinal Stem Cells
Alonso, S., & Yilmaz, Ö. H. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051644 · Cited by 73
Costa‐Machado, L. F., & Fernández-Marcos, P. J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634953 · Cited by 69
“This has been shown when SIRT1 overexpression prevented hepatocarcinoma [45], APC-driven intestinal tumors [71], and lung adenocarcinoma [58] development; Sirt2-KO mice developed spontaneous breast (females) and liver (males) tumors [100]; Sirt3-KO mice developed spontaneous mammary tumors [130]; Sirt4-KO mice spontan…”
BackgroundIntegration of β-Catenin, Sirtuin, and FOXO Signaling Protects from Mutant Huntingtin Toxicity
Parker, J. A., Vazquez-Manrique, R. P., Tourette, C., Farina, F., Offner, N., Mukhopadhyay, A., Orfila, A.-M., Darbois, A., Menet, S., Tissenbaum, H. A., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0277-12.2012 · Cited by 60
“For example, SIRT1 was reported to deacetylate -catenin and suppress its ability to activate transcription in mammalian cells (Firestein et al., 2008), which appears to contrast with our findings.”
Expression of SIRT1 in Gastric Cardiac Cancer and Its Clinicopathologic Significance
Feng, A. N., Zhang, L. H., Fan, X., Huang, Q. M., Ye, Q., Wu, H. Y., & Yang, J. (2011) · International Journal of Surgical Pathology · doi:10.1177/1066896911412181 · Cited by 65
“On the other hand, there are also studies that have concluded that SIRT1 acts as a cell grow suppressor in certain cell lineages(37-40) through deacetylation of proliferationrelated substrates and inhibition of the cell growth effect induced by those proliferation-related substrates, such as androgen receptor in prost…”
BackgroundKelly, G. S. (2010) · PubMed · Cited by 87
Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
Wu, L. E., Gomes, A. P., & Sinclair, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.005 · Cited by 62
“on their ability to halt the cell cycle, inactivate oncogenic transcription factors, and promote DNA repair, but more recent studies have shown that their effects on energy metabolism may be equal, if not more important, for tumor suppression (Figure 2; Csibi et al., 2013; Finley et al., 2011; Firestein et al., 2008;…”
InfluentialSelf-citationUpregulation of SIRT1 inhibits H2O2‑induced osteoblast apoptosis via FoxO1/β‑catenin pathway
Yao, H., Yao, Z., Zhang, S., Zhang, W., & Zhou, W. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8657 · Cited by 80
“In addition, studies had shown that subcellular localization of β ‑catenin is also affected by SIRT1 via deacetylating it (39,40).”
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Giannopoulou, A. F., Velentzas, A. D., Konstantakou, E. G., Avgeris, M., Katarachia, S. A., Papandreou, N. C., Kalavros, N., Mpakou, V., Iconomidou, V. A., Anastasiadou, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061291 · Cited by 65
Sante, G. D., Pestell, T. G., Casimiro, M. C., Bisetto, S., Powell, M. J., Lisanti, M. P., Cordon‐Cardo, C., Castillo-Martín, M., Bonal, D. M., Debattisti, V., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.09.014 · Cited by 63
“In these prior studies, SIRT1 deacetylatedb-catenin and promoted cytoplasmic localization of b-catenin.(46) The reintroduction of SIRT1 into TP53 mutant cancer cells suppresses tumor formation, likely related to a role of SIRT1 in DNA damage repair.”
BackgroundHow much successful are the medicinal chemists in modulation of SIRT1: A critical review
Kumar, A., & Chauhan, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.063 · Cited by 67
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
Farcas, M. F., Andrei-Alexandru, G., Gulei, D., Ionescu, C., Irimie, A., Cătană, C.-S., & Berindan‐Neagoe, I. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00148 · Cited by 64
“SIRT 1 may promote protective effects against HCC via its effect on β-catenin (25) —an oncogene associated with epithelial cancer (74).”
BackgroundResveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells
Li, Y., Bäckesjö, C., Haldosén, L.-A., & Lindgren, U. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.004 · Cited by 68
“Effects such as suppressing intestinal tumorigenesis and inhibition of breast cancer have also been recently reported (Firestein et al., 2008; Wang et al., 2008).”
BackgroundRole of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells
Jung-Hynes, B., & Ahmad, N. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8408 · Cited by 59
Dimitrov, V., Salehi-Tabar, R., An, B., & White, J. H. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.07.012 · Cited by 66
Noh, S. J., Kang, M. J., Kim, K. M., Bae, J. S., Park, H. S., Moon, W. S., Chung, M. J., Lee, H., Lee, D. G., & Jang, K. Y. (2013) · Pathology · doi:10.1097/pat.0b013e3283652c7a · Cited by 64
Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Talero, E., Ávila‐Román, J., & Motilva, V. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083725 · Cited by 61
“[97] have demonstrated that CR induces an increase of SIRT1 expression in the intestine of rodents.”
BackgroundHigh SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
Stenzinger, A., Endris, V., Klauschen, F., Sinn, B. V., Lorenz, K., Warth, A., Goeppert, B. F., Ehemann, V., Muckenhuber, A., Kamphues, C., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-450 · Cited by 62
“Meanwhile, many other targets have been identified, including Ku70 [8], PTEN [9], p73 [10], RelA/p65 [11], FOX01, FOX03a, and FOX04 [12], NICD [13], hypoxia-inducible factors HIF-1α, -2α [14,15], β-catenin [16], XPA [17], SMAD7 [18], and cortactin [19].”
Chung, Y.-H. (2012) · Oncology Reports · doi:10.3892/or.2012.1798 · Cited by 65
“…reported that increasing SIRT1 protein levels as a result of ectopic expression leads to reduced cell proliferation and tumor formation in a colon cancer model (40) and activation of SIRT1 activity by resveratrol also limits cell growth and reduces tumor formation in a breast cancer model (48).”
Jang, S., Min, K.-W., Paik, S. S., & Jang, K.-S. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200685 · Cited by 59
“Ectopic expression of SIRT1 in a b-catenin-driven mouse model reduced the number of intestinal adenomas and their proliferation index by inhibiting the transcriptional activity and nuclear translocation of b-catenin.(16) A tumour suppressor function of SIRT1 was also evident in a whole-body SIRT1deficient mouse model…”
BackgroundDual role of SIRT1 in UVB-induced skin tumorigenesis
Ming, M. E., Soltani, K., Shea, C. R., Li, X., & He, Y. (2014) · Oncogene · doi:10.1038/onc.2013.583 · Cited by 60
“While in vivo studies have overwhelmingly supported the tumor-suppressing role of SIRT1 in genetic or spontaneous tumorigenesis mouse models, including lymphoma, sarcoma, teratoma, carcinoma of the salivary gland and mammary gland (18), intestinal malignancies (19), liver cancer (21), and prostate neoplasia (22), SIRT…”
Role of Sirt1 Plays in Nucleus Pulposus Cells and Intervertebral Disc Degeneration
Guo, J., Shao, M., Lu, F., Jiang, J., & Xia, X. (2016) · Spine · doi:10.1097/brs.0000000000001954 · Cited by 58
Lo Sasso, G., Ryu, D., Mouchiroud, L., Fernando, S. C., Anderson, C. L., Katsyuba, E., Piersigilli, A., Hottiger, M. O., Schoonjans, K., & Auwerx, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102495 · Cited by 59
“downstream target of the Wnt signaling [12], whereas another study suggested that SIRT1 promotes the Wnt signaling both in vitro and in vivo [11].”
InfluentialZhang, T., Rong, N., Chen, J., Zou, C., Jing, H., Zhu, X., & Zhang, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079162 · Cited by 59
“Increased expression of SIRT1 has been reported in numerous types of cancer in human such as prostate cancer [14], leukemia [31], primary colon cancer [32], and breast cancer [33].”
BackgroundCharacterization of Nuclear Sirtuins: Molecular Mechanisms and Physiological Relevance
Toiber, D., Sebastián, C., & Mostoslavsky, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_9 · Cited by 60
Huang, G., Cui, F., Yu, F., Lu, H., Zhang, M., Tang, H., & Peng, Z. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.04.013 · Cited by 58
High-throughput screening of Sirtuin family of genes in breast cancer
İğci, M., Kalender, M. E., Borazan, E., Bozgeyik, İ., Bayraktar, R., Bozgeyik, E., Camcı, C., & Arslan, A. (2016) · Gene · doi:10.1016/j.gene.2016.04.023 · Cited by 60
Haploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development
Ren, N. S. X., Ji, M. H., Tokar, E. J., Busch, E. L., Xu, X., Lewis, D., Li, X., Jin, A., Zhang, Y., Wu, W. K. K., et al. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.047 · Cited by 60
“induced metabolic dysfunctions and spontaneous tumorigenesis [36–39] and displayed a reduced incidence of tumors in several cancer models [12, 40].”
Sirtuin modulators: where are we now? A review of patents from 2015 to 2019
Mautone, N., Zwergel, C., Mai, A., & Rotili, D. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1749264 · Cited by 59
Lanza‐Jacoby, S., Yan, G., Radice, G. L., LePhong, C., Baliff, J. P., & Hess, R. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213493727 · Cited by 60
“Sirt1 is overexpressed in many cancers including prostate(36) and colon cancer.(37) We found that Sirt1 protein expression was increased in the pancreas from calorie-restricted mice with expression higher in the ICR mice than in the CCR mice.”
BackgroundAllison, S. J., Jiang, M., & Milner, J. (2009) · Aging · doi:10.18632/aging.100028 · Cited by 62
Noguchi, A., Li, X., Kubota, A., Kikuchi, K., Kameda, Y., Zheng, H., Miyagi, Y., Aoki, I., & Takano, Y. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2012.12.013 · Cited by 56
Metabolic Regulation of Stem Cell Behavior and Implications for Aging
Jasper, H., & Jones, D. L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.010 · Cited by 56
“Although studies exploring a direct role for Sirtuins in influencing stem cell behavior have not been reported, it is likely that this family of enzymes will play an important role in regulating tissue homeostasis (Firestein et al., 2008; Guarente and Picard, 2005).”
BackgroundRegulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer
Baptista, T., Graça, I. C. R., Sousa, E., Oliveira, A. I., Costa, N. R., Costa‐Pinheiro, P., Amado, F. M. L., Henrique, R., & Jerónimo, C. (2013) · Oncotarget · doi:10.18632/oncotarget.1237 · Cited by 55
“Nevertheless, there is accumulating evidence that sirtuin 1 mainly acts as a tumor suppressor protein [23-25], due to its ability to promote the activity of TSC2, a repressor of mTOR [26].”
BackgroundFusco, S., Maulucci, G., & Pani, G. (2012) · Cell Cycle · doi:10.4161/cc.22074 · Cited by 54
SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer
Jung, W., Hong, K. D., Jung, W. Y., Lee, E., Shin, B. K., Kim, H. K., Kim, A., & Kim, B. (2013) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2013.47.4.332 · Cited by 59
“One study reported that SIRT1 promotes cytoplasmic localization of β-catenin in colon cancer.(6) Another study reported that altered expression of β-catenin was independently associated with poor prognosis in colon cancer.”
BackgroundHistone modifications as a pathogenic mechanism of colorectal tumorigenesis
Gargalionis, A. N., Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.002 · Cited by 53
Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets
Bruzzone, S., Parenti, M. D., Grozio, A., Ballestrero, A., Bauer, I., Río, A. D., & Nencioni, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581954 · Cited by 57
Interactions of circadian clock genes with the hallmarks of cancer
Ortega-Campos, S. M., Verdugo‐Sivianes, E. M., Amiama-Roig, A., Blanco, J. R., & Carnero, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188900 · Cited by 63
SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis.
Lin, L., Zheng, X.-X., Qiu, C., Dongol, S., Lv, Q., Jiang, J., Kong, B., & Wang, C.-G. (2014) · Oncology Report · doi:10.3892/or.2014.3521 · Cited by 53
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Huang, G., & Zhu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157724 · Cited by 55
“30 These observations were similar to the findings demonstrating that SIRT2 was downregulated in breast, 31 glioma, and skin cancers.”
SIRT1 deacetylase in aging‐induced neuromuscular degeneration and amyotrophic lateral sclerosis
Herskovits, A. Z., Hunter, T. A., Maxwell, N. D., Pereira, K., Whittaker, C. A., Valdez, G., & Guarente, L. (2018) · Aging Cell · doi:10.1111/acel.12839 · Cited by 54
Self-citationClinical and therapeutic significance of sirtuin-4 expression in colorectal cancer
Huang, G., Cheng, J., Yu, F., Liu, X., Yuan, C., Liu, C., Chen, X.-L., & Peng, Z. (2016) · Oncology Reports · doi:10.3892/or.2016.4685 · Cited by 53
Resveratrol activates SIRT1 in a Lamin A-dependent manner
Ghosh, S., Liu, B., & Zhou, Z. (2013) · Cell Cycle · doi:10.4161/cc.24061 · Cited by 58
Targeting aberrant cancer metabolism – The role of sirtuins
Kleszcz, R., Paluszczak, J., & Baer‐Dubowska, W. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.021 · Cited by 54
Chen, Z., Lin, J., Feng, S., Chen, X., Huang, H., Wang, C., Yu, Y., He, Y., Han, S., Zheng, L., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s189536 · Cited by 51
“However, other studies have found that SIRT1 expression is reduced in breast cancer,(24) and its expression in the mouse APC model blocked the formation of intestinal tumors.(25) These results are similar to those seen in the case of SIRT2, which was downregulated in breast cancer,(26) glioma,(27) and skin cancer,(28)…”
ResultSirtuin regulation in calorie restriction
Qiu, X., Brown, K. V., Moran, Y., & Chen, D. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.015 · Cited by 61
Zhang, H., FENG, Z., Huang, R., Xia, Z., Xiang, G., & Zhang, J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2596 · Cited by 51
“Increased SIRT1 expression has been found to reduce tumor formation in a mouse model of colon tumor (60,61), whereas SIRT1 mutant mice have exhibited increased DNA instability and are more susceptible to tumor development (62).”
RetractedHong, K.-S., Park, J.-I., Kim, M., Kim, H.-B., Lee, J., Đào, T. T., Oh, W. K., Kang, C., & Kim, S. H. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.025 · Cited by 51
“In contrast, SIRT1 represses β-catenin transcriptional activity by directly interacting with and deacetylating β-catenin (Firestein et al., 2008).”
BackgroundTalero, E., Alcaide, A., Ávila‐Román, J., García‐Mauriño, S., Costa, D. B. V., & Motilva, V. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.03.046 · Cited by 51
Revving the Throttle on an Oncogene: CDK8 Takes the Driver Seat
Firestein, R., & Hahn, W. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1704 · Cited by 49
“Conversely, we recently showed that the NAD-dependent deacetylase SIRT1 mediates the deacetylation and subsequent inhibition ofh-catenin transcriptional activation (12).”
BackgroundSelf-citationTherapeutic potential of activators and inhibitors of sirtuins
Balcerczyk, A., & Pirola, L. (2010) · BioFactors · doi:10.1002/biof.112 · Cited by 53
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 50
Sirtuins: The NAD + -Dependent Multifaceted Modulators of Inflammation
Santos, L., Benítez-Rosendo, A., Bresque, M., Camacho-Pereira, J., Calliari, A. J., & Escande, C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0295 · Cited by 54
“…forkhead box proteins forkhead box protein O (FOXO) transcription factors (Motta et al., 2004), but also oncogenes such as signal transducer and activator of transcription 3 (STAT3) (Lu et al., 2014), survivin (Wang et al., 2008), and b -catenin (Firestein et al., 2008), among many others (Fig.”
Singh, N. P., Singh, U. P., Hegde, V. L., Guan, H., Hofseth, L. J., Nagarkatti, M., & Nagarkatti, P. S. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000576 · Cited by 48
“The fact that SIRT1 serves as a tumor suppressor was suggested by the findings that overexpression of SIRT1 in APCmin/+ mice reduces development of colon cancer [21].”
BackgroundSirtuins, Bioageing, and Cancer
McGuinness, D. H., McGuinness, D. H., McCaul, J. A., & Shiels, P. G. (2011) · Journal of Aging Research · doi:10.4061/2011/235754 · Cited by 56
“Conversely, it can also deacetylate B-catenin causing the oncogenic form of this protein to translocate to the cytoplasm, thus reducing the growth of tumours [60].”
BackgroundHistone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders
Gediya, P., Parikh, P. K., Vyas, V. K., & Ghate, M. D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113332 · Cited by 54
SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein
Kuo, S., Lin, H., Chien, S., & Chen, D. (2013) · Oncology Reports · doi:10.3892/or.2013.2470 · Cited by 47
Cho, I.-R., Koh, S. S., Malilas, W., Srisuttee, R., Moon, J., Choi, Y. W., Horio, Y., Oh, S., & Chung, Y.-H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.107 · Cited by 54
Nguyen, P., Lee, S., Lorang-Leins, D., Trepel, J. B., & Smart, D. D. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0223-t · Cited by 50
“Firestein and colleagues have shown that SIRT1 plays a major role in inhibiting tumorigenesis and colon cancer growth by inhibiting b-catenin transcriptional activity via deacetylation (27).”
Wang, H., Han, L., Zhao, G., Shen, H., Wang, P., Sun, Z., Xu, C., Su, Y., Li, G., Tong, T., et al. (2016) · Aging Cell · doi:10.1111/acel.12511 · Cited by 51
“However, recent studies also support SIRT1 as a tumor suppressor which inhibits several oncogenic proteins such as NF-jB, b-catenin, and survivin under certain circumstances (Yeung et al., 2004; Firestein et al., 2008; Wang et al., 2008).”
BackgroundEpigenetic modifications induced by RGC-32 in colon cancer
Vlaicu, S. I., Tegla, C., Cudrici, C. D., Fosbrink, M. D., Nguyen, V., Azimzadeh, P. N., Rus, V., Chen, H., Mircea, P. A., Shamsuddin, A. M., et al. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.10.010 · Cited by 47
Jin, Y., Cao, Q., Chen, C., Du, X., Jin, B., & Pan, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1282-1 · Cited by 47
“Although the role of SIRT1 in tumorigenesis remains controversial [30-33], SIRT1 expression was shown to be significantly elevated in a number of human cancers, including acute”
BackgroundFong, Y., Lin, Y.-C., Wu, C., Wang, H., Lin, L., Chou, H. L., Teng, Y., Yuan, S. F., & Chiu, C. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/937051 · Cited by 51
“On the contrary, the previous study showed that sirt1 plays a tumor suppressive role mediated through inhibition of β-catenin [37].”
ResultZu, G., Ji, A., Zhou, T., & Che, N. (2016) · International Journal of Surgery · doi:10.1016/j.ijsu.2016.01.002 · Cited by 49
Understanding the link between cancer and neurodegeneration
Driver, J. A. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.007 · Cited by 47
The Role of SIRT1 in Tumorigenesis
Li, K., Luo, J., & Azabdaftari, G. (2011) · North American Journal of Medicine and Science · doi:10.7156/v4i2p104 · Cited by 52
Sirt1's systemic protective roles and its promise as a target in antiaging medicine
Tang, B. L. (2010) · Translational research · doi:10.1016/j.trsl.2010.11.006 · Cited by 48
White, A. T., McCurdy, C. E., Philp, A., Hamilton, D. L., Johnson, C. D., & Schenk, S. (2013) · Diabetologia · doi:10.1007/s00125-013-2912-2 · Cited by 50
“To generate mOX mice, mice harbouring loxP sites flanking a transcriptional stop element (FLX) upstream of the Sirt1 gene [13] (kindly provided by D.”
InfluentialSIRT1 inhibition in pancreatic cancer models: Contrasting effects in vitro and in vivo
Oon, C. E., Strell, C., Yeong, K. Y., Östman, A., & Prakash, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.064 · Cited by 46
NAD+ in Cancer Prevention and Treatment: Pros and Cons
Poljšak, B. (2016) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.1000165 · Cited by 48
“Although SIRT1 can promote cell survival of malignant cells, many in vivo studies indicate that Sirt1 is a tumour suppressor [21,207-209] and SIRT1 expression is reduced in different human cancers, like glioblastoma, bladder carcinoma, prostate carcinoma, and ovarian cancer [209].”
BackgroundSabir, M. S., Khan, Z., Hu, C., Galligan, M. A., Dussik, C. M., Mallick, S., Stone, A. D., Batie, S. F., Jacobs, E. T., Whitfield, G. K., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.06.010 · Cited by 45
“[53] demonstrated that SIRT1 deacetylates β-catenin, a major etiological driver of colorectal malignancies, and suppresses the ability of β-catenin to trigger transcription and drive cell growth/division.”
BackgroundKetone Bodies and SIRT1, Synergic Epigenetic Regulators for Metabolic Health: A Narrative Review
Tozzi, R., Cipriani, F., Masi, D., Basciani, S., Watanabe, M., Lubrano, C., Gnessi, L., & Mariani, S. (2022) · Nutrients · doi:10.3390/nu14153145 · Cited by 49
Sirtuin1-p53: A potential axis for cancer therapy
Yin, J., Lu, X.-T., Hou, M.-L., Cao, T., & Tian, Z. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115543 · Cited by 45
Ezhilarasan, D., Evraerts, J., Sid, B., Calderón, P. B., Karthikeyan, S., Sokal, E. M., & Najimi, M. (2017) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60166-2 · Cited by 46
SIRT1 acts as a potential tumor suppressor in oral squamous cell carcinoma
Kang, Y., Sun, F.-L., Zhang, Y., & Wang, Z. (2017) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.09.004 · Cited by 43
“A recent study reported that enhanced SIRT1 expression inhibited intestinal-tumor formation in a b-catenindependent mouse model of colon cancer, thereby indicating that the effects of SIRT1 might vary in different tumor models and may depend on the presence of appropriate downstream targets.(17) Wang et al.”
Urbán, V. S., Ceglédi, A., & Mikala, G. (2022) · GeroScience · doi:10.1007/s11357-022-00698-x · Cited by 45
Dali‐Youcef, N., Froelich, S. C., Moussallieh, F., Chibbaro, S., Noël, G., Namer, I. J., Heikkinen, S., & Auwerx, J. H. (2015) · Scientific Reports · doi:10.1038/srep09087 · Cited by 44
Cha, B.-K., Kim, Y.-S., Hwang, K., Cho, K.-H., Oh, S., Kim, B.-R., Jun, H.-Y., Yoon, K., Jeong, E., & Kim, H.-R. (2016) · Oncotarget · doi:10.18632/oncotarget.11127 · Cited by 43
“A recent report demonstrated that enhanced SIRT1 expression inhibited intestinal tumor formation in a β-catenin-dependent mouse model [47].”
BackgroundEnergy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
Yang, J., Nishihara, R., Zhang, X., Ogino, S., & Qian, Z. R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.012 · Cited by 44
“It is proved that heterozygous deletion of SIRT1 accelerates tumor formation in TP53 +/−knock-out mice [44], and overexpression of the protein reduces intestinal tumor formation in adenomatous polyposis coli (Apc) min/+ mice [45].”
BackgroundSelf-citationMiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1
Wang, X., Wang, B., Zhao, J., Liu, C., Qu, X., & Li, Y. (2018) · Bioscience Reports · doi:10.1042/bsr20181139 · Cited by 42
Alcoholic liver disease: Clinical and translational research
Neuman, M. G., Malnick, S. D. H., Maor, Y., Nanau, R. M., Melzer, E., Ferenci, P., Seitz, H. K., Mueller, S., Mell, H., Samuel, D., et al. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.09.001 · Cited by 42
SIRT1 promotes metastasis of human osteosarcoma cells
Zhang, N., Xie, T., Xian, M., Wang, Y., Li, H., Ying, M., & Ye, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12916 · Cited by 41
“SIRT1 deacetylates β-catenin, suppresses its ability to activate transcription, drives cell proliferation and inhibits intestinal tumour formation in patients with colon cancer [28].”
BackgroundAnticancer Effects of Extracts from Three Different Chokeberry Species
Gill, N., Rios, D., Osorio‐Camacena, E., Mojica, B. E., Kaur, B., Soderstrom, M. A., Gonzalez, M., Plaat, B., Poblete, C., Kaur, N., et al. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1789679 · Cited by 43
“Specifically, sirtuins are deacetylases that regulate cell metabolism but may be implicated in many types of cancers including breast (29), prostate (30), oral (31), lung (32), pancreatic (33), and colon (34) cancers.”
BackgroundAbnormal Histone Acetylation and Methylation Levels in Esophageal Squamous Cell Carcinomas
Chen, C., Zhao, M., Yin, N., He, B., Wang, B., Yuan, Y., Yu, F., Hu, J., Yin, B., & Lu, Q. (2011) · Cancer Investigation · doi:10.3109/07357907.2011.597810 · Cited by 43
“The deacetylase SIRT1 is also upregulated in a variety of cancer cell lines and tumors (42).”
BackgroundMechanisms of HDACs in cancer development
Zhang, Y., Wang, H., Zhan, Z., Gan, L., & Bai, O. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529239 · Cited by 71
“However, in a mouse model of cancer constructed by Firestein et al. (18) increased SIRT1 expression inhibited cell proliferation and tumor formation.”
The role of sirtuin proteins in obesity
Metoyer, C. F., & Pruitt, K. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.04.002 · Cited by 40
Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma
Kang, Y., Jung, W. Y., Lee, H., Lee, E., Kim, A., & Kim, B. (2012) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2012.46.6.523 · Cited by 40
“Correlations between nuclear SIRT1 expression and β-catenin expression in the cytoplasm and cell membrane in concordance with a previous study that investigated colon cancer tumorigenesis.(3) On the other hand, nuclear expression of β-catenin in this study was not correlated with SIRT1 expression, which may be due to…”
BackgroundResultInfluentialSun, W., Zhou, X., Zheng, J., Lu, M., Nie, J.-Y., Yang, X., & Zheng, Z. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr113 · Cited by 42
Calorie restriction and NAD+/sirtuin counteract the hallmarks of aging
Michán, S. (2014) · Frontiers in bioscience · doi:10.2741/4283 · Cited by 48
“SIRT1 is the most comprehensively studied sirtuin and as shown in Table 1 several protective functions have been described for it in the context of cancer, inflammation, cardiac hypertrophy and metabolic imbalance (52,183,184).”
Background
Metadata
- Authors
- Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., Hahn, W. C., Guarente, L. P., & Sinclair, D. A.
- Affiliations
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sinclair, David A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e2020
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2289879
- OpenAlex
- W2158153532
- Cited by
- 588
- References
- 34
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 12 · 2023: 29 · 2022: 11 · 2021: 25 · 2020: 15 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 38 · 2015: 31 · 2014: 40 · 2013: 60 · 2012: 46
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-06-06)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Glenn Foundation for Medical Research
- National Space Biomedical Research Institute
- National Institutes of Health (NIH T32)
- National Institute on Aging (R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- SIRT1, NAD+-dependent deacetylase, caloric restriction, intestinal tumorigenesis, colon cancer, β-catenin, protein deacetylation, cytoplasmic localization, cell proliferation, longevity genes
- MeSH terms
- Animals, Cell Nucleus, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Models, Biological, Rats, Inbred F344, Gene Expression Regulation, Neoplastic, Sirtuins, Cell Proliferation, beta Catenin, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.